Literature DB >> 32335276

Reciprocal antibiotic collateral sensitivity in Burkholderia multivorans.

Logan G Kavanaugh1, J Nicole Flanagan1, Todd R Steck2.   

Abstract

Antibiotic collateral sensitivity (CS) occurs when a bacterium that acquires resistance to a treatment drug exhibits decreased resistance to a different drug. Here we identify reciprocal CS networks and candidate genes in Burkholderia multivorans. Burkholderia multivorans was evolved to become resistant to each of six antibiotics. The antibiogram of the evolved strain was compared with the immediate parental strain to determine CS and cross-resistance. The evolution process was continued for each resistant strain. CS interactions were observed in 170 of 279 evolved strains. CS patterns grouped into two clusters based on the treatment drug being a β-lactam antibiotic or not. Reciprocal pairs of CS antibiotics arose in ≥25% of all evolved strains. A total of 68 evolved strains were subjected to whole-genome sequencing and the resulting mutation patterns were correlated with antibiograms. Analysis revealed there was no single gene responsible for CS and that CS seen in B. multivorans is likely due to a combination of specific and non-specific mutations. The frequency of reciprocal CS, and the degree to which resistance changed, suggests a long-term treatment strategy; when resistance to one drug occurs, switch to use of the other member of the reciprocal pair. This switching could theoretically be continued indefinitely, allowing life-long treatment of chronic infections with just two antibiotics.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibiotic resistance; Burkholderia; Collateral sensitivity

Mesh:

Substances:

Year:  2020        PMID: 32335276      PMCID: PMC8759574          DOI: 10.1016/j.ijantimicag.2020.105994

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  33 in total

1.  Collateral Resistance and Sensitivity Modulate Evolution of High-Level Resistance to Drug Combination Treatment in Staphylococcus aureus.

Authors:  Mari Rodriguez de Evgrafov; Heidi Gumpert; Christian Munck; Thomas T Thomsen; Morten O A Sommer
Journal:  Mol Biol Evol       Date:  2015-01-23       Impact factor: 16.240

2.  Membrane proteases and aminoglycoside antibiotic resistance.

Authors:  Aaron Hinz; Samuel Lee; Kyle Jacoby; Colin Manoil
Journal:  J Bacteriol       Date:  2011-07-15       Impact factor: 3.490

3.  Structure of the Escherichia coli heptosyltransferase WaaC: binary complexes with ADP and ADP-2-deoxy-2-fluoro heptose.

Authors:  Sylvestre Grizot; Michèle Salem; Vanida Vongsouthi; Lionel Durand; François Moreau; Hirofumi Dohi; Stéphane Vincent; Sonia Escaich; Arnaud Ducruix
Journal:  J Mol Biol       Date:  2006-07-29       Impact factor: 5.469

4.  Characterization of mutations contributing to sulfathiazole resistance in Escherichia coli.

Authors:  G Vedantam; G G Guay; N E Austria; S Z Doktor; B P Nichols
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

5.  Rapid emergence of a ceftazidime-resistant Burkholderia multivorans strain in a cystic fibrosis patient.

Authors:  Joshua R Stokell; Raad Z Gharaibeh; Todd R Steck
Journal:  J Cyst Fibros       Date:  2013-03-09       Impact factor: 5.482

6.  Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development.

Authors:  Lejla Imamovic; Morten O A Sommer
Journal:  Sci Transl Med       Date:  2013-09-25       Impact factor: 17.956

7.  Spontaneous and evolutionary changes in the antibiotic resistance of Burkholderia cenocepacia observed by global gene expression analysis.

Authors:  Andrea Sass; Angela Marchbank; Elizabeth Tullis; John J Lipuma; Eshwar Mahenthiralingam
Journal:  BMC Genomics       Date:  2011-07-22       Impact factor: 3.969

8.  Porin involvement in cephalosporin and carbapenem resistance of Burkholderia pseudomallei.

Authors:  Anuwat Aunkham; Albert Schulte; Mathias Winterhalter; Wipa Suginta
Journal:  PLoS One       Date:  2014-05-01       Impact factor: 3.240

9.  Novel glycopolymer sensitizes Burkholderia cepacia complex isolates from cystic fibrosis patients to tobramycin and meropenem.

Authors:  Vidya P Narayanaswamy; Scott Giatpaiboon; Shenda M Baker; William P Wiesmann; John J LiPuma; Stacy M Townsend
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

Review 10.  Mechanism of quinolone action and resistance.

Authors:  Katie J Aldred; Robert J Kerns; Neil Osheroff
Journal:  Biochemistry       Date:  2014-03-07       Impact factor: 3.162

View more
  3 in total

1.  The population genetics of collateral resistance and sensitivity.

Authors:  Sarah M Ardell; Sergey Kryazhimskiy
Journal:  Elife       Date:  2021-12-10       Impact factor: 8.140

2.  Antibiotic Cycling Reverts Extensive Drug Resistance in Burkholderia multivorans.

Authors:  L G Kavanaugh; S K Harrison; J N Flanagan; T R Steck
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.191

3.  Convergent phenotypic evolution towards fosfomycin collateral sensitivity of Pseudomonas aeruginosa antibiotic-resistant mutants.

Authors:  Pablo Laborda; José L Martínez; Sara Hernando-Amado
Journal:  Microb Biotechnol       Date:  2021-05-07       Impact factor: 5.813

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.